1. Home
  2. RBOT vs QNCX Comparison

RBOT vs QNCX Comparison

Compare RBOT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • QNCX
  • Stock Information
  • Founded
  • RBOT 2014
  • QNCX 2012
  • Country
  • RBOT United States
  • QNCX United States
  • Employees
  • RBOT N/A
  • QNCX N/A
  • Industry
  • RBOT Medical Specialities
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RBOT Health Care
  • QNCX Health Care
  • Exchange
  • RBOT Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • RBOT 86.1M
  • QNCX 70.4M
  • IPO Year
  • RBOT N/A
  • QNCX 2019
  • Fundamental
  • Price
  • RBOT $13.70
  • QNCX $1.58
  • Analyst Decision
  • RBOT Hold
  • QNCX Strong Buy
  • Analyst Count
  • RBOT 2
  • QNCX 4
  • Target Price
  • RBOT $10.25
  • QNCX $9.50
  • AVG Volume (30 Days)
  • RBOT 37.0K
  • QNCX 130.8K
  • Earning Date
  • RBOT 03-03-2025
  • QNCX 11-13-2024
  • Dividend Yield
  • RBOT N/A
  • QNCX N/A
  • EPS Growth
  • RBOT N/A
  • QNCX N/A
  • EPS
  • RBOT N/A
  • QNCX N/A
  • Revenue
  • RBOT N/A
  • QNCX N/A
  • Revenue This Year
  • RBOT N/A
  • QNCX N/A
  • Revenue Next Year
  • RBOT N/A
  • QNCX N/A
  • P/E Ratio
  • RBOT N/A
  • QNCX N/A
  • Revenue Growth
  • RBOT N/A
  • QNCX N/A
  • 52 Week Low
  • RBOT $4.27
  • QNCX $0.51
  • 52 Week High
  • RBOT $19.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 51.16
  • QNCX 43.92
  • Support Level
  • RBOT $12.34
  • QNCX $1.49
  • Resistance Level
  • RBOT $14.05
  • QNCX $1.69
  • Average True Range (ATR)
  • RBOT 1.30
  • QNCX 0.14
  • MACD
  • RBOT -0.09
  • QNCX 0.00
  • Stochastic Oscillator
  • RBOT 30.30
  • QNCX 46.15

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: